Improving HPV Vaccine Access to Accelerate the Elimination of Cervical Cancer in China

Duanduan Yuan, a senior medical writer, former senior reporter for the Southern Weekly health section, and visiting scholar at the Humphrey Public Health Program in the United States.

Her main focus areas are pharmaceutical and health system reform, drug review system reform, innovative drug development and regulation, cell therapy technology and regulation, tobacco control and e-cigarette policy, etc. She has participated in topics such as "International experience in management and regulation of health insurance drugs", "Strategic thinking on immunization planning", "Air pollution and mental health", etc. She is a member of the China National Institute of Health. "As a project leader, she completed the research on e-cigarettes and tobacco control. She has long been committed to the ongoing science of vaccines, infectious diseases, mental health, and other public health fields, and participated in the translation of Nobel Laureate Jennifer Doudna's book on gene editing, "Breaking the Sky: The Surprising Power of Gene Editing".

Deputy Director of Innovation Lab for Vaccine Delivery Research Ph.D., University of New South Wales, Australia; Senior Consultant, Duke University, USA

Shu (Melinda) Chen's main research areas are health policies and systems, long-term care systems, infectious disease control, and healthy aging. She has published over twenty papers as first author and co-author in high-quality international journals (e.g. The Lancet Public Health, PLOS Medicine, BMJ Global Health). Melinda was the Associate Director of Research at Family Health International (FHI 360) Beijing Office, where she led the NIH-funded TB clinical trial research and capacity-building project. Prior to joining FHI 360, she was a Research Analyst and Coordinator of the Center for Global Health Research at Duke University in Kunshan, where she worked on health policy and systems research in the areas of major infectious diseases (e.g., tuberculosis and hepatitis) and chronic diseases (e.g., stroke and coronary heart disease). Melinda also has rich experience in working with international global health funders and partners, such as the Gates Foundation, World Bank, and NIH. She received her undergraduate degree from Peking University Health Science Center, and her master's degree from Duke University, US, and is expected to obtain her Ph.D. degree from the University of New South Wales, Australia in 2023.

Jiahui Zhang, Director of Social Security and Health Care Research Department, Social and Cultural Development Research Department, Development Research Center of the State Council.

Her main research areas are health policy and elderly service policy. In the past five years, she has participated in more than 20 international and domestic cooperative research projects and served as the main coordinator for some of these projects. She has conducted in-depth and systematic research on the construction of multi-level medical security systems, improvement of graded diagnosis and treatment systems, deepening reform of drug policies, financing and salary systems of public hospitals, prevention and control strategies of major infectious diseases, scientific response to population aging, construction of elderly service systems and personnel training, and long-term care insurance. Her research and policy recommendations, such as deepening reform in the field of pharmaceuticals, conducting national negotiations on the prices of special drugs, development goals of the elderly service system, and key issues of legislation on elderly services, have been approved by leaders, playing an active role in policy adjustment in related fields.

Dr. Qiao Youlin, Professor/Doctoral Director, Chinese Academy of Medical Sciences & Peking Union Medical College, Researcher, Department of Epidemiology, Chinese Academy of Medical Sciences/Oncology Hospital, Member of WHO Global Expert Group on Cervical Cancer Eradication, Expert of WHO Strategic Advisory Group of Experts on Immunization (SAGE) HPV Working Group, Expert of International Think Tank on Chronic Disease Prevention and Control, Chinese Society of Preventive Medicine, National Health Science and Technology Commission The first batch of experts from the National Health and Health Commission's National Health Science and Technology Database.

He has been engaged in oncology epidemiology and population control research for 40 years, focusing on the etiology and attributable risk, primary and secondary prevention of cervical, esophageal, breast, and lung cancers. He has designed, led, and participated in many international collaborative studies by WHO, Bill Gates Foundation, NIH/NCI, and other globally renowned research institutions, national cancer attack, science and technology support programs, and national health industry research special projects. He has laid the groundwork for tumor and prevention and control by establishing several large sample population cohorts at high-incidence sites and accumulating a great deal of practical experience in tumor prevention and control. He created a template for cervical cancer prevention and control in the Ordos, which has contributed to the elimination of cervical cancer in China and has been called a "Chinese business card" for cervical cancer prevention and control by colleagues at home and abroad.